Skip to content
  • Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

A.L.S. Drug Relyvrio Will Be Taken Off the Market, Its Maker Says

Results of a large clinical trial found the treatment did not work any better than a placebo.

Pam Belluck
Author: Pam Belluck

Written by

Pam Belluck

in

Clinical Trials, Corporations, Drugs (Pharmaceuticals), Suits and Litigation (Civil)
←A Racially Biased Test That Prevented Thousands Of Black People From Receiving Kidney Transplants Is Finally Changing
Reworked Italian Jerseys That Celebrate Soccer Style→

More posts

  • China’s Export Boom Fuels Growth Despite Slump at Home

  • The Chiefs are 5-0 — and their offense may be returning to their dynastic heights

  • What does a White House press secretary do?

  • Burnham says youth employment and training crisis is a ‘moral failure’

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube